Thin-layer chromatography-densitometry : Determination of fenofibrate and gemfibrozil in pharmaceuticals by densitometric and videodensitometric thin-layer chromatographyKOMSTA, Łlukasz; MISZTAL, Genowefa.Journal of AOAC International. 2005, Vol 88, Num 5, pp 1517-1524, issn 1060-3271, 8 p.Article

Analysis of the complexation of gemfibrozil with γ-and hydroxypropyl-γ -cyclodextrinsFERNANDEZ, L; MARTINEZ-OHARRIZ, M. C; MARTIN, C et al.Journal of pharmaceutical and biomedical analysis. 2008, Vol 47, Num 4-5, pp 943-948, issn 0731-7085, 6 p.Article

Gemfibrozil-Induced Myositis in a Patient with Normal Renal FunctionHAHN, Martin; SRIHARAN, Kalavally; MCFARLAND, M. Shawn et al.The Annals of pharmacotherapy. 2010, Vol 44, Num 1, pp 211-214, issn 1060-0280, 4 p.Article

Gemfibrozil ConcentrationsAre Significantly Decreased in the Presence of Lopinavir-RitonavirBUSSE, Kristin H; HADIGAN, Colleen; CHAIREZ, Cheryl et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 52, Num 2, pp 235-239, issn 1525-4135, 5 p.Conference Paper

Self-micellization of gemfibrozil 1-O-β acyl glucuronide in aqueous solutionSHACKLEFORD, David M; PRANKERD, Richard J; SCANLON, Martin J et al.Pharmaceutical research. 2003, Vol 20, Num 3, pp 465-470, issn 0724-8741, 6 p.Article

Preparation of antiserum against rat Δ6-desaturase and its use to evaluate the desaturase protein levels in rats treated with gemfibrozil, a ligand for peroxisome proliferator-activated receptor αSHOJI, Yoko; SANEKATA, Ayako; SATO, Masao et al.Bioscience, biotechnology, and biochemistry. 2003, Vol 67, Num 5, pp 1177-1178, issn 0916-8451, 2 p.Article

Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statinJONES, Peter H; DAVIDSON, Michael H.The American journal of cardiology. 2005, Vol 95, Num 1, pp 120-122, issn 0002-9149, 3 p.Article

Separation of fibrate-type antihyperlipidemic drugs by capillary electrophoresis and their quantitation in pharmaceuticalsKOMSTA, Lukasz; MISZTAL, Genowefa; MAJCHRZAK, Ewa et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 2, pp 408-414, issn 0731-7085, 7 p.Article

Effect of Gemfibrozil on the Pharmacokinetics of Mitiglinide in RatsJIN, L; CAO, Q.Arzneimittel-Forschung. 2012, Vol 62, Num 1, pp 40-45, issn 0004-4172, 6 p.Article

Micronization of gemfibrozil by reactive precipitation processHUANG, Qiao-Ping; WANG, Jie-Xin; CHEN, Gui-Zhi et al.International journal of pharmaceutics. 2008, Vol 360, Num 1-2, pp 58-64, issn 0378-5173, 7 p.Article

Erythema Multiforme Associated With Gemfibrozil MonotherapyYACSAR, Hamiyet Yilmaz; ERTUGRUL, Özden; DENIZ, Coçskun et al.The American journal of the medical sciences (Print). 2010, Vol 339, Num 1, pp 86-88, issn 0002-9629, 3 p.Article

Rapid oxidation of ring methyl groups is the primary mechanism of biotransformation of gemfibrozil by the fungus Cunninghamella elegansKANG, Su-Ii; KANG, Seo-Young; KANALY, Robert A et al.Archives of microbiology. 2009, Vol 191, Num 6, pp 509-517, issn 0302-8933, 9 p.Article

Lack of hypotriglyceridemic effect of gemfibrozil as a consequence of age-related changes in rat liver PPARαSANGUINO, Elena; RAMON, Miguel; MICHALIK, Liliane et al.Biochemical pharmacology. 2004, Vol 67, Num 1, pp 157-166, issn 0006-2952, 10 p.Article

Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinideNIEMI, M; BACKMAN, J. T; NEUVONEN, M et al.Diabetologia (Berlin). 2003, Vol 46, Num 3, pp 347-351, issn 0012-186X, 5 p.Article

Increase in Tiagabine Serum Concentration with Coadministration of GemfibrozilBURSTEIN, Aaron H; BOUDREAU, Eilis A; THEODORE, William H et al.The Annals of pharmacotherapy. 2009, Vol 43, Num 2, pp 379-382, issn 1060-0280, 4 p.Article

Mechanism-Based Inactivation of CYP2C8 by Gemfibrozil Occurs Rapidly in HumansHONKALAMMI, J; NIEMI, M; NEUVONEN, P. J et al.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 4, pp 579-586, issn 0009-9236, 8 p.Article

Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemiaLAMENDOLA, Cindy; ABBASI, Fahim; CHU, James W et al.The American journal of cardiology. 2005, Vol 95, Num 2, pp 189-193, issn 0002-9149, 5 p.Article

Gemfibrozil metabolite inhibits in vitro low-density lipoprotein (LDL) oxidation and diminishes cytotoxicity induced by oxidized LDLKAWAMURA, M; MIYAZAKI, S; TERAMOTO, T et al.Metabolism, clinical and experimental. 2000, Vol 49, Num 4, pp 479-485, issn 0026-0495Article

Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern ASUPERKO, H. Robert; BERNEIS, Kaspar K; WILLIAMS, Paul T et al.The American journal of cardiology. 2005, Vol 96, Num 9, pp 1266-1272, issn 0002-9149, 7 p.Article

Gemfibrozil Is a Strong Inactivator of CYP2C8 in Very Small Multiple DosesHONKALAMMI, J; NIEMI, M; NEUVONEN, P. J et al.Clinical pharmacology and therapeutics. 2012, Vol 91, Num 5, pp 846-855, issn 0009-9236, 10 p.Article

Quantitative microscopy comparison of peroxisome proliferation by the lipid-regulating agent gemfibrozil in several speciesGRAY, R. H; DE LA IGLESIA, F. A.Hepatology (Baltimore, Md.). 1984, Vol 4, Num 3, pp 520-530, issn 0270-9139Article

Mechanism of action of gemfibrozil on lipoprotein metabolismSAKU, K; GARTSIDE, P. S; HYND, B. A et al.The Journal of clinical investigation. 1985, Vol 75, Num 5, pp 1702-1712, issn 0021-9738Article

Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamideNIEMI, Mikko; TORNIO, Aleksi; PASANEN, Marja K et al.European journal of clinical pharmacology. 2006, Vol 62, Num 6, pp 463-472, issn 0031-6970, 10 p.Article

PPARα agonists clofibrate and gemfibrozil inhibit cell growth, down-regulate hCG and up-regulate progesterone secretions in immortalized human trophoblast cellsHASHIMOTO, Fumie; OGUCHI, Yoshinobu; MORITA, Mieko et al.Biochemical pharmacology. 2004, Vol 68, Num 2, pp 313-321, issn 0006-2952, 9 p.Article

Body weight, plasma insulin, and coronary events with gemfibrozil in the Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT)ROBINS, Sander J; COLLINS, Dorothea; MCNAMARA, Judith R et al.Atherosclerosis. 2008, Vol 196, Num 2, pp 849-855, issn 0021-9150, 7 p.Article